blog counter

Kensey Nash Corporation
Medical Devices & Tech  Advamed Member
735 Pennsylvania Drive
Exton, PA 19341 USA
phone: (484) 713-2100
fax: (484) 713-2900
Symbol KNSY
Exchange Nasdaq
Founded 1984
Employees 333
www.kenseynash.com
Research Sector Medical Devices & Tech
Summary Description
Biomaterials, vascular puncture closure and embolic protection.
Management
Joseph W. Kaufmann, President and CEO; Douglas G. Evans, P.E., Chief Operating Officer; Wendy F. DiCicco, CPA, Chief Financial Officer; John E. Nash, P.E., Vice President of New Technology, Co-Founder and former, Executive Vice President; M. Kevin Carouge, Vice President; Robert A. Combs, Vice President; Donald L. Daveler, Vice President; Holly C. Harrity, Vice President; Guenter Ernst, Vice President; Todd M. DeWitt, Vice President; Robin M. Fatzinger, Vice President; Russell T. Kronengold, Ph.D., Vice President; James (Ted) Rauth, Vice President; June E. Sheets, Vice President; Gregory A. Walters, Vice President
Ownership
Financials Mkt Cap :372


* numbers in thousands

Recent Results
For the first quarter of fiscal year 2007, total revenues were $16.3 million, up 28% from the $12.7 million reported in the first quarter of fiscal 2006.
 
Keywords
wound, woundcare, advamed

Comment | Printable Version | Jul. 01, 2008
If you work for Kensey Nash Corporation and want to update this profile, click here

Description
Kensey Nash Corporation is a medical device company known for product development and technology in the fields of resorbable biomaterials and endovascular devices, used in a variety of medical procedures. The Company provides a range of products in multiple medical markets, primarily the endovascular and orthopaedic markets.
Products / Services
Kensey Nash's product offerings include the TriActiv System, which provides protection from embolic debris which can become dislodged during saphenous vein graft interventions. The Angio-Seal Vascular Closure Device, which is now manufactured, marketed and sold worldwide by St. Jude Medical, Inc., is a cardiac puncture closure device. Orthopaedic products include the VITOSS Scaffold FOAM series of products co-developed with Orthovita, Inc. KNC also manufactures several sports medicine products under private labels including meniscal repair tacks, anterior cruciate ligament (ACL) screws, soft tissue attachment screws, and trauma implants. KNC manufactures for a strategic partner a resorbable growth factor delivery matrix that is commercially available outside the United States. The company has also developed and commercialized products for oral health, wound care and cell research.
Technology / Differentiation
Awaiting Content Update
Market / Customers
KNC sells its products via its direct sales organization or through strategic alliances and distributors.
Competitors / Substitutes / Alternatives
Arrow International Inc., Datascope Corp., Vascular Solutions Inc.
Status
In fiscal 2007, the Company acquired certain assets of the MacroPore Biosurgery spinal and orthopaedic business unit of Cytori Therapeutics, Inc.
Additional Information
KNC has a European subsidiary in Eschborn, Germany.